These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33965414)

  • 21. Changes in ocular higher-order aberrations following botulinum toxin treatment in patients with blepharospasm : BTX improves dry eye in patients with BEB.
    Isshiki Y; Ishikawa H; Mimura O
    Jpn J Ophthalmol; 2016 Nov; 60(6):486-491. PubMed ID: 27503401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Botulinum toxin A treatment in patients suffering from blepharospasm and dry eye.
    Horwath-Winter J; Bergloeff J; Floegel I; Haller-Schober EM; Schmut O
    Br J Ophthalmol; 2003 Jan; 87(1):54-6. PubMed ID: 12488263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Lacrimal film evaluation of patients with facial dystonia during botulinum toxin type A treatment].
    Costa PG; Cardoso IP; Saraiva FP; Raiza AC; Tanaka LK; Matayoshi S
    Arq Bras Oftalmol; 2006; 69(3):319-22. PubMed ID: 16936952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pilot study of topical acetyl hexapeptide-8 in the treatment for blepharospasm in patients receiving botulinum toxin therapy.
    Lungu C; Considine E; Zahir S; Ponsati B; Arrastia S; Hallett M
    Eur J Neurol; 2013 Mar; 20(3):515-518. PubMed ID: 23146065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of preseptal and pretarsal injections of botulinum toxin in the treatment of blepharospasm and hemifacial spasm.
    Cakmur R; Ozturk V; Uzunel F; Donmez B; Idiman F
    J Neurol; 2002 Jan; 249(1):64-8. PubMed ID: 11954870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A patient-initiated treatment model for blepharospasm and hemifacial spasm: a randomized controlled trial.
    Lawes-Wickwar S; McBain H; Brini S; Hirani SP; Hurt CS; Flood C; Dunlop N; Solly D; Crampton B; Newman SP; Ezra DG
    BMC Neurol; 2022 Mar; 22(1):99. PubMed ID: 35300599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Dry eye and qualitative tear alteration in essential blepharospasm].
    Girard B; Begnaud S
    J Fr Ophtalmol; 2022 Mar; 45(3):288-297. PubMed ID: 35148903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Botulinum toxin injection and tear production.
    Alsuhaibani AH; Eid SA
    Curr Opin Ophthalmol; 2018 Sep; 29(5):428-433. PubMed ID: 29994851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The long-term response to botulinum toxin injections in patients with blepharospasm undergoing upper eyelid surgery.
    Trinchillo A; Cuomo N; Habetswallner F; Esposito M
    Parkinsonism Relat Disord; 2024 Feb; 119():105958. PubMed ID: 38118281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Botulinum toxin type A influence on the lacrimal function of patients with facial dystonia].
    Oliveira FC; Oliveira GC; Cariello AJ; Felberg S; Osaki MH
    Arq Bras Oftalmol; 2010; 73(5):405-8. PubMed ID: 21225122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A cross-sectional structured survey of patients receiving botulinum toxin type A treatment for blepharospasm.
    Fezza J; Burns J; Woodward J; Truong D; Hedges T; Verma A
    J Neurol Sci; 2016 Aug; 367():56-62. PubMed ID: 27423565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Electrical activation of the orbicularis oculi muscle does not increase the effectiveness of botulinum toxin type A in patients with blepharospasm.
    Conte A; Fabbrini G; Belvisi D; Marsili L; Di Stasio F; Berardelli A
    Eur J Neurol; 2010 Mar; 17(3):449-55. PubMed ID: 19968711
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transconjunctival botulinum toxin injection into the lacrimal gland in crocodile tears syndrome.
    Pattanayak S; Sharma PK; Samikhya S; Khuntia I; Patra K
    Indian J Ophthalmol; 2022 Apr; 70(4):1339-1342. PubMed ID: 35326051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Difference in response to botulinum toxin type A treatment between patients with benign essential blepharospasm and hemifacial spasm.
    Cannon PS; MacKenzie KR; Cook AE; Leatherbarrow B
    Clin Exp Ophthalmol; 2010 Oct; 38(7):688-91. PubMed ID: 20456439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Botulinum toxin type a injection for lateral canthal rhytids : effect on tear film stability and tear production.
    Ho MC; Hsu WC; Hsieh YT
    JAMA Ophthalmol; 2014 Mar; 132(3):332-7. PubMed ID: 24385079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term Efficacy of Botulinum Neurotoxin-A Treatment for Essential Blepharospasm.
    Lee S; Park S; Lew H
    Korean J Ophthalmol; 2018 Feb; 32(1):1-7. PubMed ID: 29376224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Botulinum toxin and blink rate in patients with blepharospasm and increased blinking.
    Ferrazzano G; Conte A; Fabbrini G; Bologna M; Macerollo A; Defazio G; Hallett M; Berardelli A
    J Neurol Neurosurg Psychiatry; 2015 Mar; 86(3):336-40. PubMed ID: 24963123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sustained efficacy and safety of repeated incobotulinumtoxinA (Xeomin(®)) injections in blepharospasm.
    Truong DD; Gollomp SM; Jankovic J; LeWitt PA; Marx M; Hanschmann A; Fernandez HH;
    J Neural Transm (Vienna); 2013 Sep; 120(9):1345-53. PubMed ID: 23435927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ultra-Long-Term Therapy of Benign Essential Blepharospasm with Botulinumtoxin A-30 Years of Experience in a Tertiary Care Center.
    Wabbels B; Fimmers R; Roggenkämper P
    Toxins (Basel); 2022 Feb; 14(2):. PubMed ID: 35202148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcome of Injection Botulinum Toxin in Blepharospasm.
    Amatya M; Limbu B; Sthapit PR; Gurung HB; Saiju R
    Nepal J Ophthalmol; 2021 Jan; 13(25):40-49. PubMed ID: 33981096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.